News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
October, 2024
October 2024
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
MiNK Therapeutics announced results for the fourth quarter and year-end of 2023
Photo: minkherapeutics.com
Mar 24, 2024, 13:10

MiNK Therapeutics announced results for the fourth quarter and year-end of 2023

MiNK Therapeutics shared on their LinkedIn page:

“Today MiNK announced results for the fourth quarter and year-end of 2023. Our year was marked by progress across our clinical programs, manufacturing capabilities, and research team, which continue to solidify MiNK’s leadership in the field of iNKT cell therapy.

Read more about the results and our plans for 2024 here.”

Image preview

Source: MiNK Therapeutics/LinkedIn

cancer Cell Therapy clinical progress iNKT cell therapy leadership team Medical Advancements MiNK Therapeutics OncoDaily Oncology research excellence
Special Coverage
Opinion
Oct 9, 2024, 18:07
EORTC - TMZ treatment in older patients with glioblastoma and a truly unmethylated MGMT promoter
Blog
Oct 9, 2024, 17:55
Cheri A.: New program to support research focused specifically on breast cancer in men
Blog
Oct 9, 2024, 17:48
SIOP - Progress in childhood cancer data sharing to inform policy and accelerate care and research
Blog
Oct 9, 2024, 17:39
Luis E Raez: Memorial Cancer Institute at GO2 lung cancer foundation ''Centers of Excellence'' workshop
Blog
Oct 9, 2024, 17:29
Roupen Odabashian: Fee-for-service harms both patients and physicians
Blog
Oct 9, 2024, 17:12
The EU Navigate project to support older people with cancer in 6 European countries
Blog
Oct 9, 2024, 17:01
Margaret Foti: Mobilizing the cancer research community to target RAS-driven cancers
Career
Oct 9, 2024, 16:51
Raffaele Colombo: Honored to be named one of the 2024 PharmaVoice 100
Insight
Oct 9, 2024, 16:50
Ghassan Abou-Alfa: ERBB2-altered gallbladder cancer characterization in Chile
Blog
Oct 9, 2024, 16:49
Vincent Rajkumar: mSMART Updated guidelines for newly diagnosed myeloma
Blog
Oct 9, 2024, 16:46
Vivek Subbiah: An amazing day at the AACR Industry Roundtable
Insight
Oct 9, 2024, 16:44
ctDNA during perioperative ChT in resectable gastric/GEJ cancer, summarised by Erman Akkus